China News Agency, Beijing, December 28 (Ma Shuisha) China will implement "Class B and B management" for new coronavirus infections from January 8, 2023.

With the optimization and adjustment of epidemic prevention and control policies, whether the upcoming Spring Festival travel season may lead to a new round of epidemic peaks has attracted much attention.

At present, the official has issued a document to deploy the epidemic prevention and control and transportation service guarantee work for the Spring Festival travel in 2023.

At the same time, in order to further understand and analyze the development trend of the epidemic, several provinces in China have recently launched the second round of questionnaires on the situation of people infected with the new crown.

　　The official deployment of Spring Festival travel epidemic prevention and control and transportation service guarantee work encourages "staying for the New Year" in many places

　　The "2023 Integrated Transport Spring Festival Transport Epidemic Prevention and Control and Transport Service Guarantee Overall Work Plan" issued by the Joint Prevention and Control Mechanism of the State Council on the 27th stated that the 2023 comprehensive transport Spring Festival Transport will start on January 7 and end on February 15, a total of 40 days .

With the further optimization of the epidemic prevention and control policy, the mobility of people across regions will be released at an accelerated rate. In 2023, the prevention and control of the epidemic and the guarantee of transportation services in the comprehensive transportation Spring Festival transportation will face a new situation.

　　The Ministry of Transport issued a notice on the 28th stipulating that passengers will no longer be inspected for negative nucleic acid test certificates and health codes, no landing inspections will be carried out, and temperature measurements will no longer be implemented. It is strictly forbidden to block or close expressways and service areas, ordinary roads, and waterways without authorization. Ship locks shall not arbitrarily suspend or restrict passenger transport services, and shall not restrict the movement of vehicles and people across regions, and speed up the restoration of suspended road and water passenger transport services to effectively ensure the orderly travel of the people.

　　In addition, many places have issued New Year subsidies to encourage migrant workers to "stay for the New Year".

Hangzhou, Zhejiang will issue 600 yuan consumption vouchers to every migrant worker who is not registered in Zhejiang and pays social security in Hangzhou during the Spring Festival; Platforms and postal express companies will give front-line personnel a subsidy of 60 yuan per person per day.

　　The Chinese government issued a notice on the 27th, which will optimize the measures for the exchange of Chinese and foreign personnel from January 8, 2023. Adjustments such as increasing the number of flights in stages and orderly resuming outbound travel for Chinese citizens.

As of 11:00 on the 28th, Beijing time, more than 50 Chinese embassies abroad have issued notices to adjust the prevention and control measures for travel to China.

　　Several provinces carry out questionnaire surveys on new crown infection

　　In order to monitor the development trend of the epidemic and assess the intensity of the epidemic, provinces such as Henan, Anhui, Hainan, and Sichuan have recently launched the second round of questionnaire surveys on residents' new crown infection.

The Sichuan Provincial Center for Disease Control and Prevention recently released the results of the second questionnaire survey in the province. As of 12:00 on December 25, a total of 158,506 people in the province participated in the survey, and the infection rate was 63.52%. Compared with the first round of survey results on December 19 ( 46.93%) increased by 16.59 percentage points.

　　According to the Sichuan Provincial Center for Disease Control and Prevention, another 28% of the survey population had no nucleic acid or antigen test, but had symptoms of new coronavirus infection such as fever and cough. Therefore, the actual infection rate of the new coronavirus among the survey population should be higher than 63.52%.

　　In response to rumors on the Internet that the 2020 virus strain is coming again, Yang Xiaobing, director of the Infectious Disease Prevention and Control Institute of the Wuhan Center for Disease Control and Prevention, said that monitoring data show that the current Omicron mutant strain that is prevalent in Wuhan is still BA.5.2.

From October to now, all the viruses detected in the collected samples are BA.5.2 mutant strains, and no other types of strains have been found.

　　Yang Xiaobing pointed out that after three years of changes, the main characteristics of the new coronavirus infection have evolved to include upper respiratory tract infection symptoms such as fever, headache, sore throat, and coughing. Pneumonia is no longer the main symptom, and the health hazards caused have been significantly reduced.

However, it should be noted that the new coronavirus infection is still one of the pathogens that cause lung inflammation.

If the infection does not recover for a long time, and cough, fever, chest tightness and other aggravated symptoms occur, seek medical treatment in time to prevent it from becoming severe.

　　Oximeters and oxygen concentrators are selling well. A domestic new crown oral drug will be available as soon as February next year

　　Recently, affected by the current COVID-19 epidemic, oximeters, oxygen concentrators and other products are selling well.

Many experts reminded when carrying out disease science popularization that we should be particularly alert to "silent hypoxia" in the elderly after being infected with the new crown. If the patient's blood oxygen saturation is lower than 93%, he should seek medical treatment in time.

　　In order to further improve the ability of critical care services, the Beijing Municipal Health Commission and the Beijing Municipal Medical Insurance Bureau recently jointly notified that on the basis of strengthening the community's monitoring of home isolation and rehabilitation personnel, organize the distribution of blood oxygen clips to the elderly and other high-risk groups. Self-test blood oxygen, clear and concise monitoring and early warning standards; encourage all districts to provide oxygen filling services for residents in need in community health service institutions, so as to facilitate residents' home oxygen therapy.

　　The Jiangsu Provincial Food and Drug Administration recently held a special scheduling meeting on the research progress of the new crown treatment drug SIM0417 to help the new crown treatment drug go on the market.

SIM0417 is a 3CL-targeted oral drug for the treatment of COVID-19 jointly developed by Simcere Pharmaceuticals, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Wuhan Institute of Virology.

On December 16, all 1,208 patients had been enrolled in the phase III clinical trials of the project, and the progress ranks first among domestic 3CL target drugs. It is expected to be launched in February 2023 at the earliest.

(use up)